$MIRM.US ranked positive on September 14th, 2023

Smart Insider $MIRM.US ranked positive on September 14th, 2023

$MIRM.US ranked positive on September 14th, 2023

Mirum Pharmaceuticals Inc (+1, MIRM US, September 14th)

Patrick Heron (Director since Nov. 2018) purchased $257,000 worth of stock on September 12th at $30.44. The purchase is indirect Frazier Life Sciences Healthcare, a private equity and venture capital firm where Heron has been a GP since 1999. Heron/Frazier Life, spent $3.9 million two weeks ago on a secondary offering at $26.25, and it is interesting to see them add at a higher price, in their first open market purchase in these shares. 

The company named a new CFO, Eric Bjerkholt, in September and he made his first purchase, spending $300,000. He was formerly the CFO at Chinook Therapeutics. This is the first insider buying since November 2021 when the stock was at $14. 

We are ranking the stock +1.

If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter

Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.

If you are interested in our Stocks of the Week
those services may also be useful for you


Timely data delivery customised to every user, backed by analysis tools on our internal website


We rank the stocks where transactions are most likely to indicate future share price performance


Studying buyback activity can give a clue to the fortunes of a company and help predict future share price movement

If you are a member of the media and would like to speak with a Smart Insider expert, please contact us press@smartinsider.com or call +44 203 405 3356

Scroll to Top